Unknown

Dataset Information

0

Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents.


ABSTRACT: Chloroquine (CQ) and hydroxychloroquine (HCQ) are well-known 4-aminoquinoline antimalarial agents. Scientific evidence also supports the use of CQ and HCQ in the treatment of cancer. Overall, preclinical studies support CQ and HCQ use in anti-cancer therapy, especially in combination with conventional anti-cancer treatments since they are able to sensitise tumour cells to a variety of drugs, potentiating the therapeutic activity. Thus far, clinical results are mostly in favour of the repurposing of CQ. However, over 30 clinical studies are still evaluating the activity of both CQ and HCQ in different cancer types and in combination with various standard treatments. Interestingly, CQ and HCQ exert effects both on cancer cells and on the tumour microenvironment. In addition to inhibition of the autophagic flux, which is the most studied anti-cancer effect of CQ and HCQ, these drugs affect the Toll-like receptor 9, p53 and CXCR4-CXCL12 pathway in cancer cells. In the tumour stroma, CQ was shown to affect the tumour vasculature, cancer-associated fibroblasts and the immune system. The evidence reviewed in this paper indicates that both CQ and HCQ deserve further clinical investigations in several cancer types. Special attention about the drug (CQ versus HCQ), the dose and the schedule of administration should be taken in the design of new trials.

SUBMITTER: Verbaanderd C 

PROVIDER: S-EPMC5718030 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents.

Verbaanderd Ciska C   Maes Hannelore H   Schaaf Marco B MB   Sukhatme Vikas P VP   Pantziarka Pan P   Sukhatme Vidula V   Agostinis Patrizia P   Bouche Gauthier G  

Ecancermedicalscience 20171123


Chloroquine (CQ) and hydroxychloroquine (HCQ) are well-known 4-aminoquinoline antimalarial agents. Scientific evidence also supports the use of CQ and HCQ in the treatment of cancer. Overall, preclinical studies support CQ and HCQ use in anti-cancer therapy, especially in combination with conventional anti-cancer treatments since they are able to sensitise tumour cells to a variety of drugs, potentiating the therapeutic activity. Thus far, clinical results are mostly in favour of the repurposing  ...[more]

Similar Datasets

| S-EPMC5931815 | biostudies-literature
| S-EPMC4406527 | biostudies-literature
| S-EPMC4720497 | biostudies-literature
| S-EPMC5102691 | biostudies-literature
| S-EPMC4096024 | biostudies-literature
| S-EPMC4583240 | biostudies-literature
| S-EPMC4268104 | biostudies-literature
| S-EPMC4341996 | biostudies-literature
| S-EPMC4096030 | biostudies-literature
| S-EPMC7591012 | biostudies-literature